PDIA3 and ovarian cancer: In conclusion, our data demonstrate that upregulation of select PDI family members can be considered as risk factors for ovarian cancer patients and PDI, PDIR, ERp57, ERp72 and AGR3 could be used as prognostic biomarkers.